115 related articles for article (PubMed ID: 512074)
1. Topical phosphonoacetic acid treatment of cutaneous herpes simplex infections in the guinea pig.
McCarty JR; Jarratt MT
J Am Acad Dermatol; 1979 Sep; 1(3):244-8. PubMed ID: 512074
[TBL] [Abstract][Full Text] [Related]
2. Disodium phosphonoacetate in cream base as a possible topical treatment for skin lesions of herpes simplex virus in cebus monkeys.
Palmer AE; London WT; Sever JL
Antimicrob Agents Chemother; 1977 Oct; 12(4):510-2. PubMed ID: 411417
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.
Poryo A; Wigand R
Med Microbiol Immunol; 1984; 173(4):219-24. PubMed ID: 6096685
[TBL] [Abstract][Full Text] [Related]
5. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
[TBL] [Abstract][Full Text] [Related]
6. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
Kern ER; Richards JT; Overall JC; Glasgow LA
Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.
Alenius S; Dinter Z; Oberg B
Antimicrob Agents Chemother; 1978 Sep; 14(3):408-13. PubMed ID: 213015
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the effectiveness of acycloguanosine and phosphonoacetic acid in herpetic infection in cell cultures].
L'vov ND; Samoĭlovich EO; Barinskiĭ IF
Vopr Virusol; 1986; 31(2):210-6. PubMed ID: 3014751
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs.
Helbig B; Sauerbrei A; Klöcking R; Wutzler P; Wicht N; Wiedemann U; Herrmann G
J Med Virol; 1987 Nov; 23(3):303-9. PubMed ID: 2828526
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
Park NH; Pavan-Langston D; McLean SL; Lass JH
Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
Chatis PA; Miller CH; Schrager LE; Crumpacker CS
N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
[No Abstract] [Full Text] [Related]
12. Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
Spruance SL; Freeman DJ; Sheth NV
Antimicrob Agents Chemother; 1986 Jul; 30(1):196-8. PubMed ID: 2944480
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs.
Alenius S; Oberg B
Arch Virol; 1978; 58(4):277-88. PubMed ID: 736794
[TBL] [Abstract][Full Text] [Related]
14. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.
Klein RJ; Friedman-Kien AE; Yellin PB
Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970
[TBL] [Abstract][Full Text] [Related]
15. Effect of phosphonoformate on symptomatic genital herpes simplex virus type 2 infection of guinea pigs.
Mayo DR; Lucia HL; Hsiung GD
Intervirology; 1983; 19(1):26-32. PubMed ID: 6298142
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
Ulbricht A; Färber I; Wutzler P
Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
[TBL] [Abstract][Full Text] [Related]
17. Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.
Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
Antimicrob Agents Chemother; 1979 Sep; 16(3):266-70. PubMed ID: 507784
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of pyrophosphate analogues on cutaneous herpes simplex virus type 1 infection in guinea pigs.
Wutzler P; Helbig B; Ulbricht A; Meerbach A; Pradel W
Antiviral Res; 1988 Nov; 10(1-3):99-106. PubMed ID: 2852923
[TBL] [Abstract][Full Text] [Related]
19. The effects of topical foscarnet in a new model of herpes simplex skin infection.
van Genderen J; Wolthuis OL; Ariens AT; Ericson AC; Datema R
J Antimicrob Chemother; 1987 Oct; 20(4):547-56. PubMed ID: 2960644
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous herpes simplex virus infections.
Arbesfeld DM; Thomas I
Am Fam Physician; 1991 May; 43(5):1655-64. PubMed ID: 1826983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]